Outset Medical reports Q4 rev $30.5M, FY2023 $130M (+13%), guides 2024 rev $145-153M

Outset Medical, Inc.

2023-FY EPS reported -$3.48 revenue$130,376,000

Q4 revenue $30.5M; FY2023 revenue $130M, up 13% YoY.
Installed base up 34% YoY to ~5,350 Tablo systems; consumable revenue grew nearly 50% YoY.
Recurring revenue exceeded 50% of total revenue in 2023.
Borrowed $66.5M in Jan 2024; cash position ~$270M.
2024 guidance: revenue $145-153M (12-18% growth); non-GAAP gross margin low-30% for year, mid-30% in Q4.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Outset Medical, Inc. reported the fourth quarter and fiscal year ended December 31, 2023 results: revenue $30.5 million. Guidance initiated.

Period: the fourth quarter and fiscal year ended December 31, 2023
Revenue: $30.5 million
Guidance: initiated
Result: preliminary results

Exact text from the filing

year ended December 31, 2023, and provided 2024 financial guidance. Unaudited Fourth Quarter and Year End Results, and Recent Highlights • Revenue in the fourth quarter totaled $30.5 million, bringing revenue for 2023 to $130 million, a 13% increase compared to $115 million in 2022. • Period-end installed base increased 34% year-over-year to approximately 5,350

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Outset Medical, Inc. reported the full year 2024 results: revenue between $145 million to $153 million. Guidance initiated.

Period: the full year 2024
Revenue: between $145 million to $153 million
Guidance: initiated
Result: guidance update

Exact text from the filing

Outset expects 2024 revenue to be between $145 million to $153 million

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Outset Medical, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-002731

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.